# LORATADINE
> **ANDA211718** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2023-07-28
## Drug
- **FDA Application Number:** ANDA211718
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LORATADINE
- **Generic name:** LORATADINE
- **Active ingredients:** LORATADINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** HETERO LABS LTD V
- **Manufacturer:** Camber Consumer Care Inc
- **First approval:** 2023-07-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211718)
---
*AI Analytics · CC0 1.0*